{"id":"W3129575296","doi":"10.1002/cjp2.203","title":"Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer","year":2021,"lang":"en","type":"review","venue":"The Journal of Pathology Clinical Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Chugai Pharmaceutical; Genentech; Astellas Pharma; National Institute for Health and Care Research; Incyte; Ipsen; Clovis Oncology; Royal Marsden NHS Foundation Trust; University of Chicago; Bristol-Myers Squibb; AstraZeneca; American Society of Clinical Oncology; Sanofi; Les Laboratories Pierre Fabre; Amgen; Pfizer","keywords":"Olaparib; Medicine; Prostate cancer; PARP inhibitor; Molecular diagnostics; Bioinformatics; Cancer; Computational biology; Oncology; Internal medicine; Poly ADP ribose polymerase; Gene; Polymerase; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004448536,0.0006842672,0.00123486,0.001708078,0.0002252136,0.001468202,0.001623431,0.002171057,0.002549304],"category_scores_gemma":[0.007813855,0.000331753,0.0009536431,0.001187357,0.0006909276,0.002191426,0.0008396383,0.003648791,0.001731433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007980673,"about_ca_system_score_gemma":0.002306418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001517875,"about_ca_topic_score_gemma":0.002875364,"domain_scores_codex":[0.9985222,0.0006396153,0.0002214389,0.0001383803,0.0004168333,0.00006156158],"domain_scores_gemma":[0.9956467,0.002639764,0.0004097189,0.00009002717,0.001085463,0.0001284093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007328916,0.00004857784,0.0003724256,0.01176381,0.00007884006,0.0001930319,0.00009391167,0.0005381426,0.0005853964,0.003967985,0.04309586,0.9391886],"study_design_scores_gemma":[0.00003973022,0.0001053522,0.001512841,0.01916051,0.0001745731,0.001256973,0.0001187649,0.0002803154,0.0004670691,0.00454989,0.9722993,0.00003450325],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001466901,0.9912468,0.0008217664,0.005213027,0.0005587697,0.00001971024,0.0000305309,0.00002639481,0.001936245],"genre_scores_gemma":[0.001864685,0.99176,0.002646734,0.002410653,0.0006194203,0.00003699167,0.00007184445,0.000007772643,0.0005818968],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004448536,"threshold_uncertainty_score":0.02352637,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5958416978514839,"score_gpt":0.6270654534842924,"score_spread":0.03122375563280855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}